Status:
COMPLETED
The Effect of Per Oral Immunotherapy in Severe Milk, Peanut and Egg Allergy in Adults
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Food Allergy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim is to analyse the results of per oral immunotherapy treatment in severe milk, peanut or egg allergy in adults. This is the second part of the oral immunotherapy study in adults at Skin and All...
Detailed Description
30 patients with milk allergy (at least 18 year olds), 30 patients with peanut allergy and 30 patients with egg allergy are treated with OIT. The diagnosis of food allergy is verified with positive hi...
Eligibility Criteria
Inclusion
- severe milk, peanut or egg allergy verified with positive symptom history, skin prick tests and serum IgE tests and a challenge test
Exclusion
- instable cerebrovascular or heart disease, active autoimmune disease or cancer, or current use of betablockers.
- poorly controlled asthma or FEV1 \< 70% (FEV1\< -2SD)
Key Trial Info
Start Date :
August 3 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03361072
Start Date
August 3 2017
End Date
March 11 2023
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Central Hospital
Helsinki, Finland, 00029